GlassScriptPhysician profile
Moshe Dissen
NPI 1487008389
$952.79
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $124 · 2022: $151 · 2023: $503 · 2024: $74.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $577.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $222.73 | 2022-2024 | Ozempic, Rybelsus, Wegovy |
| Gilead Sciences, INC. | $134.85 | 2019-2023 | |
| Pfizer INC. | $95.23 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.81 | 2019-2023 | Jardiance |
| Glaxosmithkline, LLC. | $56.80 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $56.55 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $54.08 | 2023-2024 | Strensiq |
| E.R. Squibb & Sons, L.L.C. | $49.22 | 2020-2023 | Eliquis |
| Biohaven Pharmaceuticals, INC. | $26.19 | 2020 | |
| Horizon Therapeutics Plc | $25.28 | 2023 | Krystexxa |
| Medtronic, INC. | $25.10 | 2023 | Intellis Adaptivestim |
| Genentech USA, INC. | $23.78 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $23.24 | 2022 | |
| Astellas Pharma US INC | $22.02 | 2020 | |
| Hologic Sales and Service, LLC | $20.95 | 2023 | Aptima, Thinprep 2000 Processor |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $16.55 | 2023 | Mounjaro, Trulicity |
| Astrazeneca Pharmaceuticals LP | $14.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moshe Dissen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.